In vivo assessment of iron content of the cerebral cortex in healthy aging using 7-Tesla T2*-weighted phase imaging

Neurobiology of Aging

Volumn 53, Issue , 2017, Pages 20-26

  Buijs, Mathijs ^a   Doan, Nhat Trung ^a   van Rooden, Sanneke ^a   Versluis, Maarten J ^a   van Lew, Baldur ^a   Milles, Julien ^a   van der Grond, Jeroen ^a   van Buchem, Mark A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

7 Tesla; Aging; Cerebral cortex; Iron; MRI; Phase

Indexed keywords

IRON; BIOLOGICAL MARKER;

ADULT; AGED; AGING; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; FEMALE; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; IRON BRAIN LEVEL; MALE; MEDICAL ASSESSMENT; MIDDLE AGED; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; VERY ELDERLY; VOLUNTEER; YOUNG ADULT; DEGENERATIVE DISEASE; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; METABOLISM; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; AGING; BIOMARKERS; CEREBRAL CORTEX; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IRON; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 85012159478     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2016.09.005     Document Type: Article

References (49)

1. Bilgic, B., Pfefferbaum, A., Rohlfing, T., Sullivan, E.V., Adalsteinsson, E., MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage 59 (2012), 2625–2635.
2. Bizzi, A., Brooks, R.A., Brunetti, A., Hill, J.M., Alger, J.R., Miletich, R.S., Francavilla, T.L., Dichiro, G., Role of iron and ferritin in MR imaging of the brain - a study in primates at different field strengths. Radiology 177 (1990), 59–65.
3. Bourgeat, P., Chetelat, G., Villemagne, V.L., Fripp, J., Raniga, P., Pike, K., Acosta, O., Szoeke, C., Ourselin, S., Ames, D., Ellis, K.A., Martins, R.N., Masters, C.L., Rowe, C.C., Salvado, O., Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology 74 (2010), 121–127.
4. Cohen-Adad, J., Polimeni, J.R., Helmer, K.G., Benner, T., McNab, J., Wald, L.L., Rosen, B.R., Mainero, C., T2* mapping and B0 orientation-dependence at 7 T reveal cyto- and myeloarchitecture organization of the human cortex. Neuroimage 60 (2012), 1006–1014.
5. Conde, J.R., Streit, W.J., Microglia in the aging brain. J. Neuropathol. Exp. Neurol. 65 (2006), 199–203.
6. Connor, J.R., Menzies, S.L., Stmartin, S.M., Mufson, E.J., Cellular-distribution of transferrin, ferritin, and iron in normal and aged human brains. J. Neurosci. Res. 27 (1990), 595–611.
7. Connor, J.R., Snyder, B.S., Beard, J.L., Fine, R.E., Mufson, E.J., Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's-disease. J. Neurosci. Res. 31 (1992), 327–335.
8. Craelius, W., Migdal, M.W., Luessenhop, C.P., Sugar, A., Mihalakis, I., Iron deposits surrounding multiple-sclerosis plaques. Arch. Pathol. Lab. Med. 106 (1982), 397–399.
9. Daugherty, A., Raz, N., Age-related differences in iron content of subcortical nuclei observed in vivo: a meta-analysis. Neuroimage 70 (2013), 113–121.
10. Deistung, A., Schäfer, A., Schweser, F., Biedermann, U., Turner, R., Reichenbach, J.R., Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. Neuroimage 65 (2013), 299–314.
11. Dexter, D.T., Wells, F.R., Agid, F., Agid, Y., Lees, A.J., Jenner, P., Marsden, C.D., Increased nigral iron content in postmortem parkinsonian brain. Lancet 2 (1987), 1219–1220.
12. DiPatre, P.L., Gelman, B.B., Microglial cell activation in aging and Alzheimer disease: partial linkage with neurofibrillary tangle burden in the hippocampus. J. Neuropathol. Exp. Neurol. 56 (1997), 143–149.
13. Doan, N.T., van Rooden, S., Versluis, M.J., Buijs, M., Webb, A.G., van der Grond, J., van Buchem, M.A., Reiber, J.H., Milles, J., An automated tool for cortical feature analysis: application to differences on 7 Tesla T2*-weighted images between young and older healthy subjects. Magn. Reson. Med., 2014.
14. Doan, N.T., van Rooden, S., Versluis, M.J., Webb, A.G., van der Grond, J., van Buchem, M., Reiber, J.H.C., Milles, J., Combined magnitude and phase-based segmentation of the cerebral cortex in 7T MR images of the elderly. J. Magn. Reson. Imaging 36 (2012), 99–109.
15. Drayer, B., Burger, P., Hurwitz, B., Dawson, D., Cain, J., Reduced signal intensity on MR images of thalamus and putamen in multiple-sclerosis–increased iron content. AJR Am. J. Roentgenol. 149 (1987), 357–363.
16. Duyn, J.H., van Gelderen, P., Li, T.Q., de Zwart, J., Koretsky, A.P., Fukunaga, M., High-field MRI of brain cortical substructure based on signal phase. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 11796–11801.
17. Farrall, A.J., Wardlaw, J.M., Blood brain barrier: ageing and microvascular disease-systematic review and meta-analysis. J. Neurol. Sci., 283, 2009, 261.
18. Fotiadis, P., van, R.S., van der Grond, J., Schultz, A., Martinez-Ramirez, S., Auriel, E., Reijmer, Y., van Opstal, A.M., Ayres, A., Schwab, K.M., Alzheimer's Disease Neuroimaging Initiative, Hedden, T., Rosand, J., Viswanathan, A., Wermer, M., Terwindt, G.M., Sperling, R.A., Polimeni, J.R., Johnson, K.A., van Buchem, M.A., Greenberg, S.M., Gurol, M.E., Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study. Lancet Neurol. 15 (2016), 811–819.
19. Fukunaga, M., Li, T.Q., Gelderen, P.V., Zwart, J.A.D., Shmueli, K., Yao, B., Lee, J., Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 3834–3839.
20. Haacke, E.M., Ayaz, M., Khan, A., Manova, E.S., Krishnamurthy, B., Gollapalli, L., Ciulla, C., Kim, I., Petersen, F., Kirsch, W., Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J. Magn. Reson. Imaging 264 (2007), 256–264.
21. Haacke, E.M., Chengb, N.Y.C., House, M.J., Liu, Q., Neelavalli, J., Ogg, R.J., Khan, A., Ayaz, M., Kirsch, W., Obenaus, A., Imaging iron stores in the brain using magnetic resonance imaging. Magn. Reson. Imaging 23 (2005), 1–25.
22. Haacke, E.M., Mittal, S., Wu, Z., Neelavalli, J., Cheng, Y.C.N., Susceptibility-weighted imaging: technical aspects and clinical applications, Part 1. AJNR Am. J. Neuroradiol 30 (2009), 19–30.
23. Haacke, E.M., Xu, Y., Cheng, Y.C., Reichenbach, J.R., Susceptibility weighted imaging (SWI). Magn. Reson. Med. 52 (2004), 612–618.
24. Hallgren, B., Sourander, P., The effect of age on the non-haemin iron in the human brain. J. Neurochem. 3 (1958), 41–51.
25. He, X., Yablonskiy, D., Biophysical mechanisms of phase contrast in gradient echo MRI. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 13558–13563.
26. Hebbrecht, G., Maenhaut, W., De Reuck, J., Brain trace elements and aging. Nucl. Instr. Methods Phys. Res. B 150 (1999), 208–213.
27. Hirai, T., Korogi, Y., Sakamoto, Y., Hamatake, S., Ikushima, I., Takahashi, M., T2 shortening in the motor cortex: effect of aging and cerebrovascular diseases. Radiology 199 (1996), 799–803.
28. House, E., Esiri, M., Forster, G., Ince, P.G., Exley, C., Aluminium, iron and copper in human brain tissues donated to the medical research council's cognitive function and ageing study. Metallomics 4 (2012), 56–65.
29. Jellinger, K., Paulus, W., Grundkeiqbal, I., Riederer, P., Youdim, M.B.H., Brain iron and ferritin in Parkinsons and Alzheimers diseases. J. Neural Transm. Park. Dis. Dement. Sect. 2 (1990), 327–340.
30. Jenner, P., Olanow, C.W., Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47 (1996), S161–S170.
31. Kakeda, S., Korogi, Y., Kamada, K., Ohnari, N., Moriya, J., Sato, T., Kitajima, M., Hasnine, H., Hirata, N., Signal intensity of the motor cortex on phase-weighted imaging at 3T. AJNR Am. J. Neuroradiol. 29 (2008), 1171–1175.
32. Killilea, D.W., Wong, S.L., Cahaya, H.S., Atamna, H., Ames, B.N., Iron accumulation during cellular senescence. Strategies for engineered negligible senescence: why genuine control of aging may be foreseeable. Ann. N.Y. Acad. Sci. 1019 (2004), 365–367.
33. Langkammer, C., Schweser, F., Krebs, N., Deistung, A., Goessler, W., Scheurer, E., Sommer, K., Reishofer, G., Yen, K., Fazekas, F., Ropele, S., Reichenbach, J.R., Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage 62 (2012), 1593–1599.
34. Lee, J., Hirano, Y., Fukunaga, M., Silva, A.C., Duyn, J.H., On the contribution of deoxy-hemoglobin to MRI gray-white matter phase contrast at high field. Neuroimage 49 (2010), 193–198.
35. Lee, J., Shmueli, K., Fukunaga, M., van Gelderen, P., Merkle, H., Silva, A.C., Duyn, J.H., Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 5130–5135.
36. Loeffler, D.A., Connor, J.R., Juneau, P.L., Snyder, B.S., Kanaley, L., Demaggio, A.J., Nguyen, H., Brickman, C.M., Lewitt, P.A., Transferrin and iron in normal, Alzheimers-disease, and Parkinsons-disease brain-regions. J. Neurochem. 65 (1995), 710–724.
37. Marques, J.P., Maddage, R., Mlynarik, V., Gruetter, R., On the origin of the MR image phase contrast: an in vivo MR microscopy study of the rat brain at 14.1 T. Neuroimage 46 (2009), 345–352.
38. Ogg, R.J., Langston, J.W., Haacke, E.M., Steen, R.G., Taylor, J.S., The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn. Reson. Imaging 17 (1999), 1141–1148.
39. Pfefferbaum, A., Adalsteinsson, E., Rohlfing, T., Sullivan, E.V., MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. Neuroimage 47 (2009), 493–500.
40. Ramos, P., Santos, A., Pinto, N.R., Mendes, R., Magalhaes, T., Almeida, A., Iron levels in the human brain: a postmortem study of anatomical region differences and age-related changes. J. Trace Elem. Med. Biol. 28 (2014), 13–17.
41. Rodrigue, K.M., Haacke, E.M., Raz, N., Differential effects of age and history of hypertension on regional brain volumes and iron. Neuroimage 54 (2011), 750–759.
42. Rowe, C.C., Ng, S., Ackermann, U., Gong, S.J., Pike, K., Savage, G., Cowie, T.F., Dickinson, K.L., Maruff, P., Darby, D., Smith, C., Woodward, M., Merory, J., Tochon-Danguy, H., O'Keefe, G., Klunk, W.E., Mathis, C.A., Price, J.C., Masters, C.L., Villemagne, V.L., Imaging beta-amyloid burden in aging and dementia. Neurology 68 (2007), 1718–1725.
43. Sadrzadeh, S.M.H., Saffari, Y., Iron and brain disorders. Am. J. Clin. Pathol. 121 (2004), S64–S70.
44. Schenck, J.F., Zimmerman, E.A., High-field magnetic resonance imaging of brain iron: birth of a biomarker?. NMR Biomed. 17 (2004), 433–445.
45. Schoenmaker, M., de Craen, A.J.M., de Meijer, P.H.E.M., Beekman, M., Blauw, G.J., Slagboom, P.E., Westendorp, R.G.J., Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. Eur. J. Hum. Genet. 14 (2006), 79–84.
46. Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., Joliot, M., Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15 (2002), 273–289.
47. Van Rooden, S., Versluis, M.J., Liem, M.K., Milles, J., Maier, A.B., Oleksik, A.M., Webb, A.G., van Buchem, M.A., van der Grond, J., Cortical phase changes in Alzheimer's disease at 7T MRI: a novel imaging marker. Alzheimers Dement. 10 (2014), e19–e26.
48. Versluis, M.J., Peeters, J.M., van Rooden, S., van der Grond, J., van Buchem, M., Webb, A.G., van Osch, M.J.P., Origin and reduction of motion and f0 artifacts in high resolution T2*-weighted magnetic resonance imaging: application in Alzheimer's disease patients. Neuroimage 51 (2010), 1082–1088.
49. Zecca, L., Youdim, M.B.H., Riederer, P., Connor, J.R., Crichton, R.R., Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5 (2004), 863–873.